Anticoagulant Treatments and Percutaneous Coronary Angioplasty

• Status: Terminated
• Trial end date: 2013-08-03
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether adjunction of intravenous anticoagulant therapy (enoxaparin, HNF, bivalirudin) to antiaggregation with clopidogrel and aspirin improves in-hospital results of percutaneous transluminal coronary angioplasty (ptca) in selected patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre Hospitalier de PAU
• Treatments: Anticoagulants; Aspirin; Bivalirudin; Clopidogrel; Enoxaparin; Heparin; Ticlopidine

Criteria

Inclusion Criteria:

• stable angina pectoris or silent ischaemia

Exclusion Criteria:

• instable angina or ACS (Acute Coronary Syndrome)